Display options
Cite
Houthuizen P, Polak PE, Edelbroek MA, et al. Giant cell arteritis as a cardiovascular entity. Neth Heart J. 2009;17(7):281-3doi: 10.1007/BF03086266.
Houthuizen, P., Polak, P. E., Edelbroek, M. A., & Peels, C. H. (2009). Giant cell arteritis as a cardiovascular entity. Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation, 17(7), 281-3. https://doi.org/10.1007/BF03086266
Houthuizen, P, et al. "Giant cell arteritis as a cardiovascular entity." Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation vol. 17,7 (2009): 281-3. doi: https://doi.org/10.1007/BF03086266
Houthuizen P, Polak PE, Edelbroek MA, Peels CH. Giant cell arteritis as a cardiovascular entity. Neth Heart J. 2009 Aug;17(7):281-3. doi: 10.1007/BF03086266. PMID: 19789695; PMCID: PMC2743816.
Copy Download .nbib Format: NLM
Share it on

Neth Heart J. 2009 Aug;17(7):281-3. doi: 10.1007/BF03086266.

Giant cell arteritis as a cardiovascular entity.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation

P Houthuizen, P E Polak, M A L Edelbroek, C H Peels

Affiliations

  1. Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands.

PMID: 19789695 PMCID: PMC2743816 DOI: 10.1007/BF03086266

Abstract

Giant cell arteritis (GCA) is a relatively infrequent disorder that is underdiagnosed and little appraised in the field of general cardiology. However, it is important to be familiar with the clinical picture of this disease, especially because of the risk of developing fatal aortic aneurysms. If the disease is suspected after a thorough history and clinical examination combined with laboratory investigation, the diagnosis can be confirmed with (18)F-2-deoxy-glucose positron emission tomographic (FDG-PET) imaging. Early recognition of giant cell arteritis followed by prompt treatment with glucocorticosteroids will decrease the risk of developing large-vessel complications. (Neth Heart J 2009;17:281-3.).

References

  1. Arthritis Rheum. 1999 Feb;42(2):311-7 - PubMed
  2. Clin Exp Rheumatol. 2000 Jul-Aug;18(4 Suppl 20):S43-8 - PubMed
  3. Rheumatology (Oxford). 2003 Mar;42(3):413-21 - PubMed
  4. N Engl J Med. 2002 Jul 25;347(4):261-71 - PubMed
  5. Curr Opin Rheumatol. 2006 Jan;18(1):10-7 - PubMed
  6. Int J Cardiol. 2000 Aug 31;75 Suppl 1:S21-33; discussion S35-6 - PubMed
  7. Eur J Nucl Med Mol Imaging. 2003 Sep;30(9):1305-13 - PubMed
  8. Arthritis Rheum. 2003 Dec;48(12):3532-7 - PubMed
  9. Neth Heart J. 2009 Aug;17(7-8):281-3 - PubMed
  10. Curr Rheumatol Rep. 2005 Aug;7(4):270-5 - PubMed

Publication Types